Navigation Links
Diagnosis of arthritis 5 years earlier in childless women compared to those with children
Date:6/11/2009

Copenhagen, Denmark, Thursday 11 June 2009: Nulliparous women (those who have not given birth to children) are diagnosed with chronic arthritides (including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) an average of 5.2 years before parous women (those who have given birth to children), according to a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

Previous studies have highlighted that pregnancy may be a protective factor against the development of RA, whereas this is the first study to assess the effect of pregnancy and having children on the development of chronic arthritic conditions in premenopausal women. Within the study, the mean age at time of diagnosis for nulliparous women was 26 years, compared with 31.2 years for parous women (p< 0.001).

Rheumatoid factor (an autoantibody sometimes found in the immune systems of people with RA) was also present in 37.1% of the nulliparous women compared with 41.1% of the parous women (p=0.21), which, although not statistically significant, may indicate that the parous women studied may possess a higher disposition to developing arthritis than the nulliparous women.

Dr Marianne Wallenius, of the Norwegian University of Science and Technology, Norway, who led the study, said: "Arthritic conditions tend to occur more commonly in women, particularly those of childbearing age. Some symptoms of RA, for example, can improve during pregnancy, but our study indicates that the processes of pregnancy and childbearing could delay the onset of arthritic conditions. Continued examination of the complex interactions between the female reproductive processes and the epidemiology of RA could yield further interesting insights."

The retrospective study analysed 557 women aged 18-45 years from the Norwegian Disease Modifying Antirheumatic Drug (NOR-DMARD) study, who were all diagnosed with chronic arthritides before the age of 45 years. Information about parous status was confirmed through linking the NOR-DMARD patient cohort with the Medical Birth Registry of Norway (MBRN).

The time of diagnosis was recorded at the time of enrollment into the study and group comparisons were performed with Mann-Whitney U test for continuous variables and chi-square tests for categorical variables. Cox multiple regression analyses were used to compare the age at diagnosis for nulliparous and parous women. The analyses were adjusted for smoking, length of education and age at the time of the current analyses.

Of the 557 women identified, 163 were nulliparous and 394 were parous (with a minimum of one delivery). The mean age at the time of the current analyses was 36.2 years for the nulliparious women, and 41.1 years for the parous women (p< 0.001).

Nulliparous women were found to have a significantly higher educational level than parous women (p=0.02), although smoking habits were not found to be significantly different between the groups (p=0.11). Unadjusted in the Cox multiple regression analyses, the nulliparous women were diagnosed at a significantly earlier age than the parous women: RR (95% CI) 1.83 (p< 0.001). However, when adjusted for educational level, smoking and age at the current analyses, a significant difference was still observed: RR (95% CI) 1.23 (p=0.04).


'/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-078-943-86425
European League Against Rheumatism
Source:Eurekalert

Related medicine news :

1. Cancer Diagnosis May Tax Physical, Mental Health
2. A real-time diagnosis for a treatable cancer
3. MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs
4. Revolutionizing the diagnosis of serious disease
5. Experts reach consensus on diagnosis and treatment of bleeding disorders in women
6. Adult Glioblastoma: Best Approaches to a Challenging Diagnosis
7. Predicting higher risk for prostate cancer diagnosis
8. Alzheimers discovery could bring early diagnosis, treatment closer
9. The Diagnosis Every Woman Dreads - Ovarian Cancer
10. Protein that suppresses androgen receptors could improve prostate cancer diagnosis, treatment
11. Haverford Wellness Center Launches Web Site Devoted to Accurate Diagnosis and Proper Treatment to Cure Lyme Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: